Latest filing published 21 Aug 2026 for Recursion Pharmaceuticals, INC., €224k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Gibson Christopher in Recursion Pharmaceuticals, Inc. The record holds 29 filings, for trades running from 5 June 2026 to 21 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 21 August 2026, reports a transaction of €224k in Recursion Pharmaceuticals, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations